Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
5,660.00
+90.00 (1.62%)
At close: Jun 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
MRO | 605.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MRO Growth | 2.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Food | 567.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Food Growth | 0.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine | 349.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Growth | 21.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -25.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 17.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -12.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -25.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Consolidated Adjustment | -25.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 1,509.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 6.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 29.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -22.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 1.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -25.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|